VSJ-110

· Vanda Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VSJ-110, covering 2024-03-06 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye [Phase 2]

See pricing